So..this week I got notice a new black box warning has been added to Paxil (probably others to follow..) Now they are identifying an increase in suicides in the young adult population (as defined by 18-24yo). We already have the warning about adolescents.
My question is - I know statistically there is an increase, which prompts the required warning, but in the real clinical setting, do you see an increase in the suicide risk with SSRI's in these two populations (adolescent & young adult) above that with initial therapy in the adult population? I'm just curious - I still have to give the written & verbal warnings which now extends from adolescence to 24 yo.
My question is - I know statistically there is an increase, which prompts the required warning, but in the real clinical setting, do you see an increase in the suicide risk with SSRI's in these two populations (adolescent & young adult) above that with initial therapy in the adult population? I'm just curious - I still have to give the written & verbal warnings which now extends from adolescence to 24 yo.